Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York October 15, 2015. REUTERS/Lucas Jackson/File Photo Acquire Licensing Rights
Oct 3 (Reuters) – A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson (JNJ.N) in a trial over four plaintiffs’ claims that they developed cancer from being exposed to the company’s talc powder products.
The Superior Court of New Jersey Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors in the case.
Reporting By Brendan Pierson in New York; editing by Jonathan Oatis
: .